Sage Therapeutics Inc (SAGE)
4.85
-0.06
(-1.22%)
USD |
NASDAQ |
Nov 21, 16:00
4.85
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Gross Profit Margin (Quarterly): 55.54% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 55.54% |
| June 30, 2024 | 83.74% |
| March 31, 2024 | 83.94% |
| December 31, 2023 | 98.95% |
| September 30, 2023 | 66.68% |
| June 30, 2023 | 91.71% |
| March 31, 2023 | 93.02% |
| December 31, 2022 | 95.01% |
| September 30, 2022 | 89.42% |
| June 30, 2022 | 86.68% |
| March 31, 2022 | 81.92% |
| Date | Value |
|---|---|
| December 31, 2021 | 94.70% |
| September 30, 2021 | 90.90% |
| June 30, 2021 | 90.99% |
| March 31, 2021 | 88.19% |
| December 31, 2020 | 99.99% |
| September 30, 2020 | 90.91% |
| June 30, 2020 | 89.90% |
| March 31, 2020 | 92.56% |
| December 31, 2019 | 88.83% |
| September 30, 2019 | 96.16% |
| June 30, 2019 | 94.96% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
55.54%
Minimum
Sep 2024
99.99%
Maximum
Dec 2020
87.68%
Average
90.40%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Outset Medical Inc | 34.26% |
| Biogen Inc | 74.10% |
| Johnson & Johnson | 69.01% |
| Lifecore Biomedical Inc | 21.81% |
| Organon & Co | 58.34% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.20% |
| Return on Assets | -43.07% |
| Return on Invested Capital | -48.20% |
| Profit Margin (Quarterly) | -788.1% |
| Operating Margin (Quarterly) | -852.5% |
| Return on Net Operating Assets | -965.1% |